Following the presentations, the posters will be available on Liquidia’s website at https://liquidia.com/publications.

Sotatercept, an activin-signaling inhibitor, reduces morbidity and mortality among patients with long-standing pulmonary arterial hypertension. Its effects in patients with pulmonary arterial ...

Tectonic Therapeutic reported positive Phase 1b trial results for TX45, showing improved hemodynamics in PH-HFpEF patients without serious adverse events. Despite the positive results, the company ...

Researchers and clinicians from the School of Biomedical Engineering & Imaging Sciences have for the first time conducted a shape analysis of the fetal aorta to detect a congenital heart defect before ...

High blood pressure can indirectly cause shortness of breath by forcing the heart to work harder, which may lead to cardiovascular issues. Pulmonary hypertension, a specific type of high blood ...